Barclay Alec

Chief Operations Officer at T2 Biosystems, Inc.

Sold, on record
$55k
Dollars the filings state
Form 4 sales
4
Latest Mar 17, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Sep 11, 2019 2019

    Sold 4,210 shares at $2.92 ($12k)

    Barclay Alec, SVP, Operations

    Sold 9.1% of holdings ($135k position)42,102 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Feb 24, 2020 +166 days

    Sold 5,808 shares at $0.82 ($5k)

    Barclay Alec, SVP, Operations

    Sold 11.1% of holdings ($43k position)46,294 shares leftFiling

  3. 3 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Feb 23, 2021 +365 days

    Sold 7,280 shares at $2.06 ($15k)

    Barclay Alec, Chief Operations Officer

    Sold 10% of holdings ($149k position)65,247 shares leftFiling

  4. 4 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Mar 17, 2021 +22 days

    Sold 12,494 shares at $1.86 ($23k)

    Barclay Alec, Chief Operations Officer

    Sold 14.4% of holdings ($162k position)74,420 shares left2.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Barclay Alec
Source
Mar 17, 2021Mar 18, 2021T2 Biosystems, Inc.Chief Operations OfficerForm 4 sale12,494$23k14.4%Plan not statedSEC
Feb 23, 2021Feb 23, 2021T2 Biosystems, Inc.Chief Operations OfficerForm 4 sale7,280$15k10.0%Plan not statedSEC
Feb 24, 2020Feb 25, 2020T2 Biosystems, Inc.SVP, OperationsForm 4 sale5,808$5k11.1%Plan not statedSEC
Sep 11, 2019Sep 13, 2019T2 Biosystems, Inc.SVP, OperationsForm 4 sale4,210$12k9.1%Plan not statedSEC